Insiders · Profile

Jalota Deepika

Chief Development Officer at PMV Pharmaceuticals. Filing since 17 Aug 2021. CIK 0001825192

Company
Date
Role
Action
Shares
Amount
Of holding
1 Jul 2025
Chief Development Officer
Sold at will
33,065
$35.20K
26.9%
11 Sep 2024
Chief Development Officer
Sold at will
7,218
$10.85K
5.8%
15 Sep 2023
Chief Development Officer
Sold at will
4,104
$27.17K
12.1%
17 Aug 2021
SVP, Regulatory Affairs and QA
Sold, plan not stated
2,896
$97.81K
100%
4 decisions on file.